MMP9 and achalasia-alacrima syndrome: Furthermore, MMP-1 alongside MMP-9 were identified as elevated in the plasma of patients with ruptured AAAs when compared with individuals harbouring intact AAAs, with MMP-9 levels also associating with 30-day mortality (156).